Axillary Lymph Node Dissection: Still a Necessary Procedure?

Lince Valadares, S; Oliveira, S; Pires, F; Sereno, P; Mira, R

http://hdl.handle.net/10400.17/4157

Use this identifier to reference this record.

Name:	Description:	Size:	Format:
Acta Obstet Ginecol Port 2016_230.pdf		185.08 KB	Adobe PDF	Download

Send Feedback

Authors

Abstract(s)

Sentinel lymph node biopsy (SLNB) is the gold standard procedure for breast cancer staging and axillary lymph node dissection (AD) is recommended when metastasis are found. Two recent practice-changing studies altered this paradigm. They brought into discussion old unanswered questions, such as the impact of AD on morbidity, survival and choice of adjuvant therapy as well as new questions, like the role of radiotherapy and the omission of AD after positive SLNB. The authors reviewed the literature focusing on these issues and concluded that AD after positive SLNB can be omitted in selected cases.